ReviewReviews in endocrine & metabolic disorders2026
LEAP2 as a therapeutic target in obesity and cardiometabolic disorders.
Stephanie K Holm et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewReviews in endocrine & metabolic disorders2026
Stephanie K Holm et al.PubMed ↗Publisher ↗
No numbers read from the abstract.